Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add filters








Type of study
Year range
1.
Chinese Journal of Natural Medicines (English Ed.) ; (6): 264-273, 2015.
Article in English | WPRIM | ID: wpr-812148

ABSTRACT

Scutellarin (SCU), a flavonoid from a traditional Chinese medicinal plant. Our previous study has demonstrated that SCU relaxes mouse aortic arteries mainly in an endothelium-depend-ent manner. In the present study, we investigated the vasoprotective effects of SCU against HR-induced endothelial dysfunction (ED) in isolated rat CA and the possible mechanisms involving cyclic guanosine monophosphate (cGMP) dependent protein kinase (PKG). The isolated endothelium-intact and endothelium-denuded rat CA rings were treated with HR injury. Evaluation of endothelium-dependent and -independent vasodilation relaxation of the CA rings were performed using wire myography and the protein expressions were assayed by Western blotting. SCU (10-1 000 μmol·L(-1)) could relax the endothelium-intact CA rings but not endothelium-denuded ones. In the intact CA rings, the PKG inhibitor, Rp-8-Br-cGMPS (PKGI-rp, 4 μmol·L(-1)), significantly blocked SCU (10-1 000 μmol·L(-1))-induced relaxation. The NO synthase (NOS) inhibitor, NO-nitro-L-arginine methylester (L-NAME, 100 μmol·L(-1)), did not significantly change the effects of SCU (10-1 000 μmol·L(-1)). HR treatment significantly impaired ACh-induced relaxation, which was reversed by pre-incubation with SCU (500 μmol·L(-1)), while HR treatment did not altered NTG-induced vasodilation. PKGI-rp (4 μmol·L(-1)) blocked the protective effects of SCU in HR-treated CA rings. Additionally, HR treatment reduced phosphorylated vasodilator-stimulated phosphoprotein (p-VASP, phosphorylated product of PKG), which was reversed by SCU pre-incubation, suggesting that SCU activated PKG phosphorylation against HR injury. SCU induces CA vasodilation in an endothelium-dependent manner to and repairs HR-induced impairment via activation of PKG signaling pathway.


Subject(s)
Animals , Rats , Apigenin , Pharmacology , Cell Adhesion Molecules , Cell Hypoxia , Coronary Vessels , Cyclic GMP , Metabolism , Pharmacology , Cyclic GMP-Dependent Protein Kinases , Glucuronates , Pharmacology , Microfilament Proteins , NG-Nitroarginine Methyl Ester , Metabolism , Pharmacology , Phosphoproteins , Rats, Sprague-Dawley , Reperfusion Injury , Signal Transduction , Thionucleotides , Metabolism , Pharmacology , Vasodilation , Physiology
2.
Asian Pacific Journal of Tropical Medicine ; (12): 986-989, 2013.
Article in English | WPRIM | ID: wpr-819744

ABSTRACT

OBJECTIVE@#To investigate the effects of Xinjikang on the left ventricular hypertrophy remodeling and myocardial activity in hypertension.@*METHODS@#Sixty Wistar rats were randomly divided into four groups. The pressure-loaded left ventricular hypertrophy model was established with abdominal aorta ligation method. Rats in A and B groups were intragastrically administered with physiological saline, while C and D groups were administered with Xinjikang and metoprolol, respectively. The changes in blood pressure, E/A ratio, myocardial pathological morphology, myocardial lipoperoxides and superoxide dismustase activity in four groups were observed and compared before and after treatment.@*RESULTS@#There were statistically significant differences in E/A ratio between C group after treatment and model group (P0.05); after treatment the myocardial lipoperoxides and superoxide dismustase contents in C and D groups were improved significantly compared with model group (P<0.05).@*CONCLUSIONS@#Xinjikang can improve myocardial injury, restore myocardial parenchyma and myocardial interstitial remodeling functions in hypertensive rats with the left ventricular hypertrophy.


Subject(s)
Animals , Female , Male , Rats , Antihypertensive Agents , Pharmacology , Therapeutic Uses , Blood Pressure , Drugs, Chinese Herbal , Pharmacology , Therapeutic Uses , Hypertension , Drug Therapy , Metoprolol , Pharmacology , Therapeutic Uses , Myocardium , Chemistry , Pathology , Rats, Wistar , Ventricular Remodeling
3.
Chinese Journal of Medical Genetics ; (6): 706-710, 2013.
Article in Chinese | WPRIM | ID: wpr-254531

ABSTRACT

<p><b>OBJECTIVE</b>To assess the association between single nucleotide polymorphism in M-type phospholipase A2 receptor (PLA2R) gene and membranous nephropathy (MN) in a Chinese Han population.</p><p><b>METHODS</b>A total of 430 non-related Chinese Hans were enrolled, which included 145 patients with idiopathic membranous nephropathy (IMN), 53 patients with secondary MN and 232 normal controls (NC). The polymorphism of rs35771982 in PLA2R gene was determined with polymerase chain reaction-restriction fragment length polymorphism assay. Serum anti-PLA2R antibodies were detected by Western blotting.</p><p><b>RESULTS</b>The genotypic and allelic frequencies for rs35771982 was significantly different among the three groups (P=0.004; P<0.001). CC genotype and C allele were significantly more common in IMN group compared with NC group (P=0.002; P<0.001) or secondary MN group (P=0.011; P=0.001). In the IMN group, the CC genotype was correlated with serum albumin (Alb), 24-hour urine protein (24h UP) and positive rate of serum anti-PLA2R antibody (P<0.001, P<0.001, P=0.010), and was a risk factor for IMN (OR=8.927, 95%CI:2.107-37.821, P=0.003).</p><p><b>CONCLUSION</b>The CC genotype and C allele at rs35771982 in PLA2R gene are associated with susceptibility to IMN in Chinese Hans. The associations between CC genotype and severity of IMN as well as serum anti-PLA2R antibody have indicated that production of anti-PLA2R autoantibody in IMN patients is associated with mutation at the rs35771982 locus of PLA2R gene.</p>


Subject(s)
Adult , Female , Humans , Male , Middle Aged , Young Adult , Alleles , Asian People , Genetics , Gene Frequency , Genetic Predisposition to Disease , Genotype , Glomerulonephritis, Membranous , Genetics , Polymorphism, Single Nucleotide , Receptors, Phospholipase A2 , Genetics
4.
Chinese Journal of Preventive Medicine ; (12): 1064-1068, 2009.
Article in Chinese | WPRIM | ID: wpr-316060

ABSTRACT

<p><b>OBJECTIVE</b>To study the effect of lycopene on red blood cell and the level of blood lipid.</p><p><b>METHODS</b>According to the level of serum total cholesterol and weight, forty-eight adult male SD rats were divided randomly into six groups: normal control (group A), fed by normal feed; hyperlipidemia group (group B): fed by high fat diet; positive control group (group C): fed by high fat diet plus 10 mg * kg(-1) * d(-1) fluvastatin sodium; lycopene groups: fed by high fat diet plus 11 (group D), 22 (group E), 44 mg * kg(-1) * d(-1) (group F) lycopene through gavage, respectively. For all six groups, the level of serum total cholesterol (TC) and total triglyceride (TG) were measured at the end of 0, 1, 3 weeks of the study by taking samples from tail vein. At the end of the experiment, RBC and HGB were measured.</p><p><b>RESULTS</b>After the rats were fed with high-fat feed for a week, models of hyperlipidemia rats were established. At the end of 3 weeks, TC of group A, B, C, D, E and F were (1.31 +/- 0.05), (19.40 +/- 0.54), (4.66 +/- 0.07), (7.18 +/- 0.06), (5.30 +/- 0.28), (4.49 +/- 0.23) mmol/L (F = 4395.72, P = 0.00), respectively;and TG were (0.42 +/- 0.01), (2.29 +/- 0.42), (0.69 +/- 0.03), (1.10 +/- 0.05), (0.63 +/- 0.02), (0.62 +/- 0.04) mmol/L (F = 127.26, P = 0.00), respectively; HGB were (143.13 +/- 6.33), (112.63 +/- 2.56), (124.75 +/- 3.62), (124.63 +/- 7.78), (132.38 +/- 6.41), (142.13 +/- 5.54) g/L (F = 34.14, P = 0.00), respectively; RBC were (6.75 +/- 0.60) x 10(12)/L, (5.08 +/- 0.75) x 10(12)/L, (7.14 +/- 0.82) x 10(12)/L, (5.94 +/- 1.09) x 10(12)/L, (6.18 +/- 0.36) x 10(12)/L and (7.31 +/- 0.58) x 10(12)/L (F = 10.35, P = 0.00), respectively.</p><p><b>CONCLUSION</b>Lycopene have some protective effects on red blood cells of the hyperlipidemic rats by regulating the blood lipid and antioxidant.</p>


Subject(s)
Animals , Male , Rats , Carotenoids , Pharmacology , Cholesterol , Blood , Cholesterol, LDL , Blood , Erythrocytes , Hypercholesterolemia , Blood , Lipids , Blood , Rats, Sprague-Dawley , Triglycerides , Blood
SELECTION OF CITATIONS
SEARCH DETAIL